Neos Therapeutics Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rebounds, but yield surge sets stage for weekly losses
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
- SpaceX shares fall as second lockup period ends
Neos Therapeutics (NEOS) IPO Opens 21% Higher
July 23, 2015 10:29 AM EDTToday's IPO for Neos Therapeutics (NASDAQ: NEOS) opened for trading at $18.22 after pricing 4,800,000 shares of common stock at an initial public offering price of $15.00 per share.
UBS Investment Bank, BMO Capital Markets and RBC Capital Markets are acting as joint book-running... More
Neos Therapeutics (NEOS) Prices 4.8M Common Stock IPO at $15/Share, at Middle of Range
July 23, 2015 9:27 AM EDTNeos Therapeutics, Inc. ("Neos" or "the Company") (Nasdaq: NEOS) announced the pricing of its initial public offering of 4,800,000 shares of common stock at an initial public offering price of $15.00 per share. In addition, Neos has granted the underwriters a 30-day option to purchase up... More
